BIOG-B.STBIOG-B.STSTO
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+2.3%
5Y CAGR-3.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+2.3%/yr
Quarterly compound
5Y CAGR
-3.3%/yr
Recent acceleration
Percentile
P90
Near historical high
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 42.17% |
| Q3 2025 | -14.85% |
| Q2 2025 | 34.07% |
| Q1 2025 | -32.88% |
| Q4 2024 | -52.69% |
| Q3 2024 | 166.12% |
| Q2 2024 | 6.82% |
| Q1 2024 | -12.33% |
| Q4 2023 | 38.86% |
| Q3 2023 | -46.85% |
| Q2 2023 | 107.75% |
| Q1 2023 | -40.56% |
| Q4 2022 | 39.34% |
| Q3 2022 | -19.19% |
| Q2 2022 | 12.08% |
| Q1 2022 | -18.29% |
| Q4 2021 | 54.57% |
| Q3 2021 | -29.81% |
| Q2 2021 | 3.36% |
| Q1 2021 | -8.28% |
| Q4 2020 | 49.85% |
| Q3 2020 | -26.77% |
| Q2 2020 | -4.40% |
| Q1 2020 | 20.13% |
| Q4 2019 | -11.35% |
| Q3 2019 | -5.60% |
| Q2 2019 | 4.41% |
| Q1 2019 | -9.76% |
| Q4 2018 | 18.51% |
| Q3 2018 | -0.74% |
| Q2 2018 | 30.64% |
| Q1 2018 | -18.27% |
| Q4 2017 | 35.75% |
| Q3 2017 | -0.90% |
| Q2 2017 | 4.93% |
| Q1 2017 | -7.21% |
| Q4 2016 | 10.63% |
| Q3 2016 | 4.58% |
| Q2 2016 | 15.01% |
| Q1 2016 | -15.19% |